# Nutrition, Inflammation and Insulin Resistance in End-Stage Renal Disease

> **NCT04067752** · NA · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 18 (actual)

## Conditions studied

- End-stage Renal Disease

## Interventions

- **OTHER:** high dialysate sodium concentration (138 mEq/L)
- **OTHER:** Low dialysate sodium concentration

## Key facts

- **NCT ID:** NCT04067752
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-01
- **Primary completion:** 2024-05-15
- **Final completion:** 2024-05-20
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04067752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04067752, "Nutrition, Inflammation and Insulin Resistance in End-Stage Renal Disease". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04067752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*